About Atul Bioscience Limited
Data last updated: 21 December 2025
Atul Bioscience Limited is a public limited company based in Atul, Gujarat, India, a subsidiary of Atul Limited. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 21 May 1997, the company has been in operation for over 29 years.
Registered with ROC Ahmedabad under CIN U24230GJ1997PTC032369.
Capital: an authorised share capital of ₹60 Cr and a paid-up capital of ₹29.02 Cr. Formerly known as Atul Pharmaceuticals Limited. It is led by directors including Rangaswamy Rathakrishnan Iyer and Latika Prakash Pradhan.
Last AGM: 10 July 2025. Financial statements filed for year ended 31 March 2025. Office: E – 12 East Site, Atul, Gujarat, India – 396020.
As per the financials filed for FY 2025, the company reported a revenue of ₹136.8 Cr, a growth of 3% compared to the previous year.
The company has a workforce of approximately 170 employees as per the latest available data. It operates as a subsidiary of Atul Limited.
The company is associated with 1 brand - Atul. As per MCA filings, the company has open charges of ₹45 Cr and satisfied charges of ₹58.75 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website atulbio.co.in.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressE – 12 East Site, Atul, Gujarat, India – 396020
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Atul Bioscience Limited
Atul Bioscience Limited has one previous CIN (Corporate Identification Number): U24230GJ1997PTC032369. The current CIN is U24230GJ1997PLC032369, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230GJ1997PLC032369 | Current |
| U24230GJ1997PTC032369 | Previous |
Associated Brands with Atul Bioscience Limited
Atul Bioscience Limited operates one associated brand: Atul. These brands represent Atul Bioscience Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Fine chemicals are manufactured by Atul in Ahmedabad, India. | atul.co.in |
Business Activity of Atul Bioscience Limited
Atul Bioscience Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Board of Directors of Atul Bioscience Limited
Atul Bioscience Limited is currently managed by 11 directors, with 20 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rangaswamy Rathakrishnan Iyer | Director | 19 Jan 2011 | 15 Years 5 Months | Current |
| Latika Prakash Pradhan | Director | 22 Oct 2021 | 4 Years 8 Months | Current |
| Pramod Hari Lele | Director | 19 Jan 2011 | 15 Years 5 Months | Current |
|
Prabhakar Chebiyyam
Also directs:
Atul Lifescience Limited, Atul Healthcare Limited
|
Managing Director | 11 Jul 2014 | 11 Years 11 Months | Current |
|
Sunil Siddharth Lalbhai
Also directs:
Britannia Industries Ltd, The Bombay Dyeing And Manufacturing Company Limited, Amal Limited and 4 more
|
Director | 11 Dec 2008 | 17 Years 6 Months | Current |
|
Astha Sunil Lalbhai
Also directs:
Atul Consumer Products Limited, Aagam Holdings Private Limited
|
Director | 12 Oct 2018 | 7 Years 8 Months | Current |
Financials of Atul Bioscience Limited FY 2025 filings available
Atul Bioscience Limited reported revenue of ₹136.8 Cr (up 3% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Atul Bioscience Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jul 2024 | Others | ₹40 Cr | Open |
| 07 Jun 2011 | Axis Bank Limited | ₹5 Cr | Open |
| 08 Mar 2019 | Others | ₹40 Cr | Satisfied |
| 25 Jul 2012 | Axis Bank Ltd | ₹7.5 Cr | Satisfied |
| 07 Jun 2011 | Axis Bank Limited | ₹11.25 Cr | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Atul Bioscience Limited
View historical data on people associated with Atul Bioscience Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Atul Bioscience Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Atul Bioscience Limited
GSTIN & GST Filing Data of Atul Bioscience Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Atul Bioscience Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Atul Bioscience Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Atul Bioscience Limited
MSME Payment Delays by Atul Bioscience Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Atul Bioscience Limited
Subsidiaries & Group Companies of Atul Bioscience Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Atul Bioscience Limited with ownership details.
MCA Filings & Documents of Atul Bioscience Limited
MCA Filings & Documents of Atul Bioscience Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Atul Bioscience Limited
Recent News on Atul Bioscience Limited
Frequently Asked Questions about Atul Bioscience Limited
Atul Bioscience Limited is an active public limited company in the pharma sector based in Atul, Gujarat, India. It was incorporated on 21 May 1997 (29+ years old) and is registered under CIN U24230GJ1997PLC032369. The company has 170 employees.
Atul Bioscience Limited reported revenue of ₹136.8 Cr for FY 2025 (up 3.00% YoY).
The current directors of Atul Bioscience Limited are:
The primary industry of Atul Bioscience Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Atul Bioscience Limited can be reached at the registered office: E – 12 East Site, Atul, Gujarat, India – 396020, or through the website atulbio.co.in.
The authorised capital is ₹60 Cr, and the paid-up capital is ₹29.02 Cr.